Last updated on November 2019

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care


Brief description of study

The main purpose of this study is to see how GLPG1690 works together with your current standard treatment on your lung function and IPF disease in general. The study will also investigate how well GLPG1690 is tolerated (for example if you get any side effects while on study drug).

Clinical Study Identifier: NCT03711162

Find a site near you

Start Over

Austin Health

Heidelberg, Australia
3.47miles
  Connect »

The Alfred Hospital

Melbourne, Australia
6.21miles
  Connect »

Box Hill Hospital

Box Hill, Australia
8.42miles
  Connect »